Cargando…

The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility

INTRODUCTION: It remains unclear why the optimal haemoglobin target is lower in patients with chronic kidney disease (CKD) than in non-CKD persons. Arteriosclerosis and consequent impaired arterial function comprise a central cardiovascular risk mechanism in CKD. We hypothesized that the optimal hae...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Hon-Chun, Robinson, Chanel, Norton, Gavin R, Woodiwiss, Angela J, Dessein, Patrick H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779802/
https://www.ncbi.nlm.nih.gov/pubmed/33408501
http://dx.doi.org/10.2147/IJNRD.S285168
_version_ 1783631402192863232
author Hsu, Hon-Chun
Robinson, Chanel
Norton, Gavin R
Woodiwiss, Angela J
Dessein, Patrick H
author_facet Hsu, Hon-Chun
Robinson, Chanel
Norton, Gavin R
Woodiwiss, Angela J
Dessein, Patrick H
author_sort Hsu, Hon-Chun
collection PubMed
description INTRODUCTION: It remains unclear why the optimal haemoglobin target is lower in patients with chronic kidney disease (CKD) than in non-CKD persons. Arteriosclerosis and consequent impaired arterial function comprise a central cardiovascular risk mechanism in CKD. We hypothesized that the optimal haemoglobin target depends on its opposing effects on arterial stiffness and pressure pulsatility in CKD. METHODS: Arterial stiffness (aortic pulse wave velocity), wave reflection (augmentation index, reflected wave pressure and reflection magnitude), and pressure pulsatility (central systolic and pulse pressure, peripheral pulse pressure, pressure amplification and forward wave pressure) were assessed in 48 dialysis patients. RESULTS: In established confounder and diabetes adjusted linear regression models, haemoglobin levels were directly associated with arterial stiffness (partial R=0.366, p=0.03) and inversely with central systolic pressure (partial R=−0.344, p=0.04), central pulse pressure (partial R=−0.403, p=0.01), peripheral pulse pressure (partial R=−0.521, p=0.001) and forward wave pressure (partial R=−0.544, p=0.001). The presence of heart failure and use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and erythropoietin stimulating agents did not materially alter these relationships upon further adjustment for the respective characteristics in the models, and in sensitivity analyses. In receiver operator characteristic curve analysis, the optimal haemoglobin concentration cut-off values in predicting arterial stiffness and increased central pulse pressure were remarkably similar at 10.95 g/dl and 10.85 g/dl, respectively, and with clinically useful sensitivities, specificities and positive and negative predictive values. In logistic regression models, a haemoglobin value of >10.9 mg/dl was associated with both arterial stiffness (>10 m/sec; OR (95% CI) = 10.48 (1.57–70.08), p=0.02) and normal central pulse pressure (>50 mmHg; OR (95% CI) = 7.55 (1.58–36.03), p=0.01). CONCLUSION: This study suggests that the optimal haemoglobin target in dialysis patients is ~11g/dl and determined by its differential and contrasting effects on arterial stiffness and pressure pulsatility.
format Online
Article
Text
id pubmed-7779802
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77798022021-01-05 The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility Hsu, Hon-Chun Robinson, Chanel Norton, Gavin R Woodiwiss, Angela J Dessein, Patrick H Int J Nephrol Renovasc Dis Original Research INTRODUCTION: It remains unclear why the optimal haemoglobin target is lower in patients with chronic kidney disease (CKD) than in non-CKD persons. Arteriosclerosis and consequent impaired arterial function comprise a central cardiovascular risk mechanism in CKD. We hypothesized that the optimal haemoglobin target depends on its opposing effects on arterial stiffness and pressure pulsatility in CKD. METHODS: Arterial stiffness (aortic pulse wave velocity), wave reflection (augmentation index, reflected wave pressure and reflection magnitude), and pressure pulsatility (central systolic and pulse pressure, peripheral pulse pressure, pressure amplification and forward wave pressure) were assessed in 48 dialysis patients. RESULTS: In established confounder and diabetes adjusted linear regression models, haemoglobin levels were directly associated with arterial stiffness (partial R=0.366, p=0.03) and inversely with central systolic pressure (partial R=−0.344, p=0.04), central pulse pressure (partial R=−0.403, p=0.01), peripheral pulse pressure (partial R=−0.521, p=0.001) and forward wave pressure (partial R=−0.544, p=0.001). The presence of heart failure and use of angiotensin converting enzyme inhibitors or angiotensin receptor blockers and erythropoietin stimulating agents did not materially alter these relationships upon further adjustment for the respective characteristics in the models, and in sensitivity analyses. In receiver operator characteristic curve analysis, the optimal haemoglobin concentration cut-off values in predicting arterial stiffness and increased central pulse pressure were remarkably similar at 10.95 g/dl and 10.85 g/dl, respectively, and with clinically useful sensitivities, specificities and positive and negative predictive values. In logistic regression models, a haemoglobin value of >10.9 mg/dl was associated with both arterial stiffness (>10 m/sec; OR (95% CI) = 10.48 (1.57–70.08), p=0.02) and normal central pulse pressure (>50 mmHg; OR (95% CI) = 7.55 (1.58–36.03), p=0.01). CONCLUSION: This study suggests that the optimal haemoglobin target in dialysis patients is ~11g/dl and determined by its differential and contrasting effects on arterial stiffness and pressure pulsatility. Dove 2020-12-30 /pmc/articles/PMC7779802/ /pubmed/33408501 http://dx.doi.org/10.2147/IJNRD.S285168 Text en © 2020 Hsu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hsu, Hon-Chun
Robinson, Chanel
Norton, Gavin R
Woodiwiss, Angela J
Dessein, Patrick H
The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
title The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
title_full The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
title_fullStr The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
title_full_unstemmed The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
title_short The Optimal Haemoglobin Target in Dialysis Patients May Be Determined by Its Contrasting Effects on Arterial Stiffness and Pressure Pulsatility
title_sort optimal haemoglobin target in dialysis patients may be determined by its contrasting effects on arterial stiffness and pressure pulsatility
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779802/
https://www.ncbi.nlm.nih.gov/pubmed/33408501
http://dx.doi.org/10.2147/IJNRD.S285168
work_keys_str_mv AT hsuhonchun theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT robinsonchanel theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT nortongavinr theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT woodiwissangelaj theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT desseinpatrickh theoptimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT hsuhonchun optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT robinsonchanel optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT nortongavinr optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT woodiwissangelaj optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility
AT desseinpatrickh optimalhaemoglobintargetindialysispatientsmaybedeterminedbyitscontrastingeffectsonarterialstiffnessandpressurepulsatility